Immunotherapy With Racotumomab in Advanced Lung Cancer
Phase 3
- Conditions
- NSCLCLung Cancer, Non-small Cell
- Interventions
- Biological: RacotumomabOther: Best Support Treatment
- First Posted Date
- 2011-10-26
- Last Posted Date
- 2016-07-29
- Lead Sponsor
- Recombio SL
- Target Recruit Count
- 1082
- Registration Number
- NCT01460472
- Locations
- 🇨🇺
Hospital "Celestino Hernández Robau", Provincia de Villa Clara, Cuba
🇵ðŸ‡Veterans Memorial Medical Center, Manila, Philippines
🇦🇷PoliclÃnica Privada Instituto de Medicina Nuclear, BahÃa Blanca, Argentina
© Copyright 2025. All Rights Reserved by MedPath